Exclusive: EU antitrust regulators likely to block Illumina, Grail deal – sources
BRUSSELS – EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said on Wednesday. There are doubts…